Skip to main content

The “Company Name” field currently displays the company associated with the drug identification number (DIN) as of today. A fix will be implemented shortly so the fields will show the company name as it was when the report was originally posted. This issue does not impact the data that can be extracted from the website using the Application Programming Interface (API).

Reports for APO-ESOMEPRAZOLE

Brand name

APO-ESOMEPRAZOLE

Company Name

APOTEX INC

Drug Identification Number

02339099

Ingredients & Strength

ESOMEPRAZOLE (20 MG)

ATC Code

A02BC

ATC Descriptor

DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)

Status

MARKETED

Shortage reports
Brand name	Packaging size	Status	Date Created	Date Updated	Reports
APO-ESOMEPRAZOLE	100 BTL	Resolved	2020-02-05	2020-03-03	105330
APO-ESOMEPRAZOLE	100 BTL	Resolved	2020-03-18	2020-05-19	108939
APO-ESOMEPRAZOLE	30 BLS and 100 BTL	Resolved	2020-06-04	2021-09-20	116536
APO-ESOMEPRAZOLE	100 BTL and 30 BLS	Resolved	2022-09-01	2022-09-16	168359
APO-ESOMEPRAZOLE	30 BLS	Resolved	2023-06-09	2023-07-27	194568
APO-ESOMEPRAZOLE	100 BTL	Resolved	2024-04-12	2024-04-19	224984
APO-ESOMEPRAZOLE	30 BLS	Resolved	2024-05-03	2024-05-31	227073
APO-ESOMEPRAZOLE	100 BTL	Resolved	2024-07-12	2024-08-09	232815
APO-ESOMEPRAZOLE	30 BLS	Resolved	2025-11-06	2025-11-21	271260
APO-ESOMEPRAZOLE	100 BTL	Actual shortage	2025-11-14	2026-01-15	271937

1
2
Next

Showing 1 to 10 of 11

Discontinuation reports
Brand name	Packaging size	Status	Date Created	Date Updated	Reports

1

Showing 1 to 0 of 0